Self-delivery of a peptide-based prodrug for tumor-targeting therapy

Nano Research

Volumn 9, Issue 3, 2016, Pages 663-673

  Peng, Mengyun ^a   Qin, Siyong ^a,b   Jia, Huizhen ^a   Zheng, Diwei ^a,c   Rong, Lei ^a   Zhang, Xianzheng ^a  

^a WUHAN UNIVERSITY   (China)

^b SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

^c HUBEI UNIVERSITY   (China)

Author keywords

prodrug; self assembly; self delivery; tumor targeting therapy

Indexed keywords

AMINO ACIDS; CONTROLLED DRUG DELIVERY; NANOSYSTEMS; SELF ASSEMBLY; TUMORS;

CAMPTOTHECIN (CPT); CELLULAR INTERNALIZATION; FIBRILLAR STRUCTURES; HYDROLYTIC CLEAVAGE; PRODRUGS; SELF-DELIVERY; THERAPEUTIC EFFICACY; TUMOR TARGETING;

TARGETED DRUG DELIVERY;

EID: 84959547563     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-015-0945-1     Document Type: Article

References (34)

1. Allen, T. M.; Cullis, P. R. Liposomal drug delivery systems: From concept to clinical applications. Adv. Drug Deliv. Rev.2013, 65, 36–48.
2. Ding, J. X.; Chen, L. H.; Xiao, C. S.; Chen, L.; Zhuang, X. L.; Chen, X. S. Noncovalent interaction-assisted polymeric micelles for controlled drug delivery. Chem. Commun.2014, 50, 11274–11290.
3. Yu, J. M.; Xie, X.; Xu, X. Y.; Zhang, L.; Zhou, X. Y.; Yu, H.; Wu, P.; Wang, T.; Che, X. X.; Hu, Z. H. Development of dual ligand-targeted polymeric micelles as drug carriers for cancer therapy in vitro and in vivo. J. Mater. Chem. B2014, 2, 2114–2126.
4. Zhang, J.; Yuan, Z. F.; Wang, Y.; Chen, W. H.; Luo, G. F.; Cheng, S. X.; Zhuo, R. X.; Zhang, X. Z. Multifunctional envelope-type mesoporous silica nanoparticles for tumortriggered targeting drug delivery. J. Am. Chem. Soc.2013, 135, 5068–5073.
5. Liang, R. Z.; Wei, M.; Evans, D. G.; Duan, X. Inorganic nanomaterials for bioimaging, targeted drug delivery and therapeutics. Chem. Commun.2014, 50, 14071–14081.
6. Li, Z. Y.; Hu, J. J.; Xu, Q.; Chen, S.; Jia, H. Z.; Sun, Y. X.; Zhuo, R. X.; Zhang, X. Z. A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles. J. Mater. Chem. B2015, 3, 39–44.
7. Xiang, X.; Ding, X. C.; Moser, T.; Gao, Q.; Shokuhfar, T.; Heiden, P. A. Peptide-directed self-assembly of functionalized polymeric nanoparticles. Part II: Effects of nanoparticle composition on assembly behavior and multiple drug loading ability. Macromol. Biosci.2015, 15, 568–582.
8. Xiao, D.; Jia, H. Z.; Ma, N.; Zhuo, R. X.; Zhang, X. Z. A redox-responsive mesoporous silica nanoparticle capped with amphiphilic peptides by self-assembly for cancer targeting drug delivery. Nanoscale2015, 7, 10071–10077.
9. Shen, Y. Q.; Jin, E. L.; Zhang, B.; Murphy, C. J.; Sui, M. H.; Zhao, J.; Wang, J. Q.; Tang, J. B.; Fan, M. H.; van Kirk, E. et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J. Am. Chem. Soc.2010, 132, 4259–4265.
10. Huttunen, K. M.; Raunio, H.; Rautio, J. Prodrugs-from serendipity to rational design. Pharmacol. Rev.2011, 63, 750–771.
11. Bui, D. T.; Maksimenko, A.; Desmaële, D.; Harrisson, S.; Vauthier, C.; Couvreur, P.; Nicolas, J. Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy. Biomacromolecules2013, 14, 2837–2847.
12. Yuan, Y. Y.; Kwok, R. T. K.; Tang, B. Z.; Liu, B. Targeted theranostic platinum(IV) prodrug with a built-in aggregationinduced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. J. Am. Chem. Soc.2014, 136, 2546–2554.
13. Chen, W. H.; Luo, G. F.; Lei, Q.; Jia, H. Z.; Hong, S.; Wang, Q. R.; Zhuo, R. X.; Zhang, X. Z. MMP-2 responsive polymeric micelles for cancer-targeted intracellular drug delivery. Chem. Commun.2015, 51, 465–468.
14. Cheetham, A. G.; Zhang, P. C.; Lin, Y. A.; Lock, L. L.; Cui, H. G. Supramolecular nanostructures formed by anticancer drug assembly. J. Am. Chem. Soc.2013, 135, 2907–2910.
15. Li, S. Y.; Liu, L. H.; Jia, H. Z.; Qiu, W. X.; Rong, L.; Cheng, H.; Zhang, X. Z. A pH-responsive prodrug for real-time drug release monitoring and targeted cancer therapy. Chem. Commun.2014, 50, 11852–11855.
16. Huang, P.; Wang, D. L.; Su, Y.; Huang, W.; Zhou, Y. F.; Cui, D. X.; Zhu, X. Y.; Yan, D. Y. Combination of small molecule prodrug and nanodrug delivery: Amphiphilic drug–drug conjugate for cancer therapy. J. Am. Chem. Soc.2014, 136, 11748–11756.
17. Zhang, T.; Huang, P.; Shi, L. L.; Su, Y.; Zhou, L. Z.; Zhu, X. Y.; Yan, D. Y. Self-assembled nanoparticles of amphiphilic twin drug from floxuridine and bendamustine for cancer therapy. Mol. Pharmaceutics2015, 12, 2328–2336.
18. Standley, S. M.; Toft, D. J.; Cheng, H.; Soukasene, S.; Chen, J.; Raja, S. M.; Band, V.; Band, H.; Cryns, V. L.; Stupp, S. I. Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res.2010, 70, 3020–3026.
19. Jiang, X.; Qu, W.; Pan, D.; Ren, Y.; Williford, J. M.; Cui, H. G.; Luijten, E.; Mao H. Q. Plasmid-templated shape control of condensed DNA-block copolymer nanoparticles. Adv. Mater.2013, 25, 227–232.
20. Kim, S. H.; Kaplan, J. A.; Sun, Y.; Shieh, A.; Sun, H. L.; Croce, C. M.; Grinstaff, M. W.; Parquette, J. R. The selfassembly of anticancer camptothecin-dipeptide nanotubes: A minimalistic and high drug loading approach to increased efficacy. Chem.—Eur. J.2015, 21, 101–105.
21. Garlich, J. R.; De, P.; Dey, N.; Su, J. D.; Peng, X. D.; Miller, A.; Murali, R.; Lu, Y. L.; Mills, G. B.; Kundra, V. et al. A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity. Cancer Res.2008, 68, 206–215.
22. Fairbanks, B. D.; Schwartz, M. P.; Halevi, A. E.; Nuttelman, C. R.; Bowman, C. N.; Anseth, K. S. A versatile synthetic extracellular matrix mimic via thiol-norbornene photopolymerization. Adv. Mater.2009, 21, 5005–5010.
23. Qin, S. Y.; Jiang, H. F.; Peng, M. Y.; Lei, Q.; Zhuo, R. X.; Zhang, X. Z. Adjustable nanofibers self-assembled from an irregular conformational peptide amphiphile. Polym. Chem.2015, 6, 519–524.
24. Das, P.; Jana, N. R. Dopamine functionalized polymeric nanoparticle for targeted drug delivery. RSC Adv.2015, 5, 33586–33594.
25. Cheng, H.; Cheng, Y. J.; Bhasin, S.; Zhu, J. Y.; Xu, X. D.; Zhuo, R. X.; Zhang, X. Z. Complementary hydrogen bonding interaction triggered co-assembly of an amphiphilic peptide and an anti-tumor drug. Chem. Commun.2015, 51, 6936–6939.
26. Cui, H. G.; Webber, M. J.; Stupp, S. I. Self-assembly of peptide amphiphiles: From molecules to nanostructures to biomaterials. Biopolymers2010, 94, 1–18.
27. Nabiev, I.; Fleury, F.; Kudelina, I.; Pommier, Y.; Charton, F.; Riou, J. F.; Alix, A. J. P.; Manfait, M. Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family. Biochem. Pharmacol.1998, 55, 1163–1174.
28. Qin, S. Y.; Peng, M. Y.; Rong, L.; Li, B.; Wang, S. B.; Cheng, S. X.; Zhuo, R. X.; Zhang, X. Z. Self-defensive nano-assemblies from camptothecin-based antitumor drugs. Regen. Biomat.2015, 2, 159–166.
29. Yang, Z. M.; Liang, G. L.; Xu, B. Supramolecular hydrogels based on β-amino acid derivatives. Chem. Commun.2006, (7), 738–740.
30. Qin, S. Y.; Pei, Y.; Liu, X. J.; Zhuo, R. X.; Zhang, X. Z. Hierarchical self-assembly of β-amyloid peptide derivative. J. Mater. Chem. B2013, 1, 668–675.
31. Lee, M. H.; Kim, J. Y.; Han, J. H.; Bhuniya, S.; Sessler, J. L.; Kang, C.; Kim. J. S. Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug. J. Am. Chem. Soc.2012, 134, 12668–12674.
32. Oussoren, C.; Storm, G. Liposomes to target the lymphatics by subcutaneous administration. Adv. Drug Deliv. Rev.2001, 50, 143–156.
33. Lee, H.; Yu, M. K.; Park, S.; Moon, S.; Min, J. J.; Jeong, Y. Y.; Kang, H.-W.; Jon, S. Thermally cross-linked superparamagnetic iron oxide nanoparticles: Synthesis and application as a dual imaging probe for cancer in vivo. J. Am. Chem. Soc.2007, 129, 12739–12745.
34. Koo, O. M. Y.; Rubinstein, I.; Önyüksel, H. Actively targeted low-dose camptothecin as a safe, long-acting, diseasemodifying nanomedicine for rheumatoid arthritis. Pharm. Res.2011, 28, 776–787.